{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:36:12Z","timestamp":1792557372383,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"SCOHIA PHARMA, Inc."},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.phrs.2020.105337","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T14:11:34Z","timestamp":1606831894000},"page":"105337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice"],"prefix":"10.1016","volume":"163","author":[{"given":"Jun","family":"Sugama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Moritoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"Tsuchimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2020.105337_bib0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbadis.2017.01.016","article-title":"Dynamics of diabetes and obesity: epidemiological perspective","volume":"1863","author":"Boles","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.phrs.2020.105337_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2017.05.013","article-title":"Obesity and hypertension","volume":"122","author":"Seravalle","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2020.105337_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"Suppl 3","key":"10.1016\/j.phrs.2020.105337_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"A.A.C.E.O.C.P.G. Reviewers of the, American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract."},{"issue":"Suppl","key":"10.1016\/j.phrs.2020.105337_bib0025","article-title":"Efficacy of lifestyle modification for long-term weight control","volume":"12","author":"Wadden","year":"2004","journal-title":"Obes. Res."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrendo.2017.122","article-title":"Current pharmacotherapy for obesity","volume":"14","author":"Srivastava","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2020.105337_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2019.03.011","article-title":"The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases","volume":"49","author":"Pascale","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2020.105337_bib0040","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1073\/pnas.95.12.6578","article-title":"Prokaryotes: the unseen majority","volume":"95","author":"Whitman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.phrs.2020.105337_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1756283X13482996","article-title":"Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ","volume":"6","author":"Guinane","year":"2013","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"7122","key":"10.1016\/j.phrs.2020.105337_bib0050","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.phrs.2020.105337_bib0055","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7122","key":"10.1016\/j.phrs.2020.105337_bib0060","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2020.105337_bib0065","first-page":"242","article-title":"Enteropeptidase, a type II transmembrane serine protease","volume":"1","author":"Zheng","year":"2009","journal-title":"Front Biosci (Elite Ed)"},{"issue":"5","key":"10.1016\/j.phrs.2020.105337_bib0070","doi-asserted-by":"crossref","first-page":"e00517","DOI":"10.1002\/prp2.517","article-title":"Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792","volume":"7","author":"Sasaki","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"10","key":"10.1016\/j.phrs.2020.105337_bib0075","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/dom.13799","article-title":"SCO-792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice","volume":"21","author":"Yashiro","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2020.105337_bib0080","article-title":"Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease","author":"Sugama","year":"2020","journal-title":"Diabetes Obes. Metab."},{"issue":"6052","key":"10.1016\/j.phrs.2020.105337_bib0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.phrs.2020.105337_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition","volume":"11","author":"Rinninella","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.phrs.2020.105337_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s13300-017-0226-y","article-title":"Effects of acarbose on the gut microbiota of prediabetic patients: a randomized, double-blind, controlled crossover trial","volume":"8","author":"Zhang","year":"2017","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.phrs.2020.105337_bib0100","article-title":"Orlistat-induced gut microbiota modification in obese mice","volume":"2020","author":"Ke","year":"2020","journal-title":"Evid. Complement. Alternat. Med."},{"key":"10.1016\/j.phrs.2020.105337_bib0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mimet.2014.07.029","article-title":"Comparison of seven methods for extraction of bacterial DNA from fecal and cecal samples of mice","volume":"105","author":"Ferrand","year":"2014","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.phrs.2020.105337_bib0110","doi-asserted-by":"crossref","first-page":"16643","DOI":"10.1038\/srep16643","article-title":"Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice","volume":"5","author":"Schneeberger","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2020.105337_bib0115","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1039\/c0mb00141d","article-title":"Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia","volume":"7","author":"Ooga","year":"2011","journal-title":"Mol. Biosyst."},{"issue":"2","key":"10.1016\/j.phrs.2020.105337_bib0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1039\/B714176A","article-title":"Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS","volume":"4","author":"Ohashi","year":"2008","journal-title":"Mol. Biosyst."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"issue":"15","key":"10.1016\/j.phrs.2020.105337_bib0130","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/jssc.201101121","article-title":"Alternative method for gas chromatography-mass spectrometry analysis of short-chain fatty acids in faecal samples","volume":"35","author":"Garcia-Villalba","year":"2012","journal-title":"J. Sep. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2020.105337_bib0135","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1021\/acs.molpharmaceut.6b00259","article-title":"Effect of intestinal flora on protein expression of drug-metabolizing enzymes and transporters in the liver and kidney of germ-free and antibiotics-treated mice","volume":"13","author":"Kuno","year":"2016","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: relationships with disease and opportunities for therapy","volume":"216","author":"Durack","year":"2019","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.105337_bib0145","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2020.105337_bib0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fmicb.2020.00219","article-title":"Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.phrs.2020.105337_bib0155","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gutjnl-2014-308778","article-title":"Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology","volume":"65","author":"Dao","year":"2016","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.phrs.2020.105337_bib0160","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.phrs.2020.105337_bib0165","first-page":"308","article-title":"The human gut microbiota: metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"10.1016\/j.phrs.2020.105337_bib0170","doi-asserted-by":"crossref","first-page":"110893","DOI":"10.1016\/j.nut.2020.110893","article-title":"Abundance of the species Clostridium butyricum in the gut microbiota contributes to differences in obesity phenotype in outbred Sprague-Dawley CD rats","volume":"78","author":"Obanda","year":"2020","journal-title":"Nutrition"},{"issue":"7456","key":"10.1016\/j.phrs.2020.105337_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2020.105337_bib0180","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2014.07.016","article-title":"Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature","volume":"28","author":"Sweeney","year":"2014","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"178","key":"10.1016\/j.phrs.2020.105337_bib0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005687","article-title":"Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity","volume":"5","author":"Liou","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0190","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/EJE-17-0403","article-title":"Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery","volume":"178","author":"Guo","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1462-2920.13589","article-title":"Formation of propionate and butyrate by the human colonic microbiota","volume":"19","author":"Louis","year":"2017","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.phrs.2020.105337_bib0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.phrs.2020.105337_bib0205","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1073\/pnas.1016088108","article-title":"Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)","volume":"108","author":"Kimura","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cmet.2016.06.013","article-title":"Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis","volume":"24","author":"De Vadder","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2020.105337_bib0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mam.2017.04.001","article-title":"Bile acids and bariatric surgery","volume":"56","author":"Albaugh","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"9","key":"10.1016\/j.phrs.2020.105337_bib0225","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ismej.2017.71","article-title":"Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding","volume":"11","author":"Ilhan","year":"2017","journal-title":"ISME J."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","article-title":"IgA and the intestinal microbiota: the importance of being specific","volume":"13","author":"Pabst","year":"2020","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2020.105337_bib0235","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.163.2.913","article-title":"Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection","volume":"163","author":"Lycke","year":"1999","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2020.105337_bib0240","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/eji.201242543","article-title":"Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice","volume":"42","author":"Reikvam","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.105337_bib0245","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1038\/s41467-019-11370-y","article-title":"Gut-associated IgA(+) immune cells regulate obesity-related insulin resistance","volume":"10","author":"Luck","year":"2019","journal-title":"Nat. Commun."},{"issue":"80","key":"10.1016\/j.phrs.2020.105337_bib0250","doi-asserted-by":"crossref","first-page":"80re2","DOI":"10.1126\/scitranslmed.3002043","article-title":"Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss","volume":"3","author":"Laferrere","year":"2011","journal-title":"Sci. Transl. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820316455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:15:03Z","timestamp":1760912103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820316455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"alternative-id":["S1043661820316455"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105337","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.105337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105337"}}